Shareholder alert: weiss law investigates seagen inc.

New york , march 14, 2023 /prnewswire/ -- weiss law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of seagen inc. ("seagen" or the "company") (nasdaq: sgen) in connection with the proposed acquisition of the company by pfizer inc. (nyse: pfe).  under the terms of the merger agreement, the company's shareholders will receive $229.00 in cash for each share of seagen owned.
SGEN Ratings Summary
SGEN Quant Ranking